Oxiconazole
Azole Antifungal — DERMATOLOGICALS
Also known as: oxiconazole nitrate, oxyconazole, Ro 13-8996
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Oxiconazole is an ofp drug in the Azole Antifungal class catalogued in DrugCentral. It was first approved by the FDA in 1988. DrugCentral lists 26 molecular targets, including CYP2C19, CYP3A4 and ADORA3. Recorded indications include Pityriasis versicolor, Tinea corporis, Tinea cruris and Tinea pedis.
- Approval status: ofp (first approved 1988 by the FDA).
- Drug class: Azole Antifungal.
- Molecular targets: CYP2C19, CYP3A4, ADORA3 and SLC6A4 (26 listed in DrugCentral).
- Indications: Pityriasis versicolor, Tinea corporis, Tinea cruris and Tinea pedis.
- ATC code: D01AC11 (Imidazole and triazole derivatives).
- Molecular formula: C18H13Cl4N3O; molecular weight 429.12 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (4)
- Pityriasis versicolor
- Tinea corporis
- Tinea cruris
- Tinea pedis
Contraindications (1)
- Skin irritation
Mechanism & targets
| Established pharmacologic class | Azole Antifungal |
|---|
Molecular targets (26)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Cytochrome P450 2C19 | CYP2C19 | unknown | IC50 7.40 |
| Cytochrome P450 3A4 | CYP3A4 | unknown | IC50 7.05 |
| Adenosine receptor A3 | ADORA3 | unknown | Ki 6.45 |
| Sodium-dependent serotonin transporter | SLC6A4 | unknown | Ki 6.37 |
| Alpha-2C adrenergic receptor | ADRA2C | unknown | Ki 6.22 |
| Thromboxane-A synthase | TBXAS1 | unknown | IC50 6.21 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 6.17 |
| Muscarinic acetylcholine receptor M3 | CHRM3 | unknown | Ki 6.02 |
| Cytochrome P450 2D6 | CYP2D6 | unknown | IC50 6.00 |
| Substance-K receptor | TACR2 | unknown | Ki 5.97 |
| Muscarinic acetylcholine receptor M1 | CHRM1 | unknown | Ki 5.94 |
| 5-hydroxytryptamine receptor 2A | HTR2A | unknown | Ki 5.92 |
| Alpha-2A adrenergic receptor | ADRA2A | unknown | Ki 5.82 |
| Alpha-2B adrenergic receptor | ADRA2B | unknown | Ki 5.78 |
| Delta-type opioid receptor | OPRD1 | unknown | Ki 5.73 |
| Sodium-dependent noradrenaline transporter | SLC6A2 | unknown | Ki 5.72 |
| D(1A) dopamine receptor | DRD1 | unknown | Ki 5.68 |
| Sodium-dependent dopamine transporter | SLC6A3 | unknown | Ki 5.68 |
| 5-hydroxytryptamine receptor 2B | HTR2B | unknown | Ki 5.53 |
| Cytochrome P450 2C9 | CYP2C9 | unknown | IC50 5.52 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1988-12-30 | FDA | — | FOUGERA PHARMS |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
D01AC11 | DERMATOLOGICALS › ANTIFUNGALS FOR DERMATOLOGICAL USE › ANTIFUNGALS FOR TOPICAL USE › Imidazole and triazole derivatives |
G01AF17 | GENITO URINARY SYSTEM AND SEX HORMONES › GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS › ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS › Imidazole derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Oxiconazole is on its molecule page.
| Molecular formula | C18H13Cl4N3O |
|---|---|
| Molecular weight | 429.12 g/mol |
| CAS number | 64211-45-6 |
| InChIKey | QRJJEGAJXVEBNE-HKOYGPOVSA-N |
| PubChem CID | 5353853 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Oxiconazole used for?
DrugCentral lists the following indications for Oxiconazole: Pityriasis versicolor, Tinea corporis, Tinea cruris and Tinea pedis.
How does Oxiconazole work?
Its molecular targets in DrugCentral include CYP2C19, CYP3A4, ADORA3 and SLC6A4.
When was Oxiconazole first approved?
Oxiconazole was first approved by the FDA in 1988.
What drug class does Oxiconazole belong to?
Oxiconazole is in the Azole Antifungal class.
What is the chemical formula of Oxiconazole?
Oxiconazole has the molecular formula C18H13Cl4N3O and a molecular weight of 429.12 g/mol.
Browse: all drugs starting with O · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3408 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200836 — compound record and bioactivity
- PubChem CID 5353853 — chemical identifiers
- DrugBank DB00239 — drug record
- FDA UNII C668Q9I33J — substance identity
- DailyMed: FDA labels for Oxiconazole — current prescribing information (label search)
- UniProt P33261 (CYP2C19) — target protein
- UniProt P08684 (CYP3A4) — target protein
- UniProt P0DMS8 (ADORA3) — target protein
- UniProt P31645 (SLC6A4) — target protein
- UniProt P18825 (ADRA2C) — target protein
- UniProt P24557 (TBXAS1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.